Química médica y biológica - MedChemLab
QUÍMICA MÉDICA
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (6)
2023
-
Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
Neuropharmacology, Vol. 240
2015
-
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
International Journal of Cancer, Vol. 136, Núm. 9, pp. 2078-2090
-
Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer
Journal of the National Cancer Institute, Vol. 107, Núm. 6
2012
-
New synthetic inhibitors of fatty acid synthase with anticancer activity
Journal of Medicinal Chemistry, Vol. 55, Núm. 11, pp. 5013-5023
2010
-
Molecular recognition of peloruside A by microtubules. The C24 primary alcohol is essential for biological activity
ChemBioChem, Vol. 11, Núm. 12, pp. 1669-1678
2009
-
Novel inhibitors of fatty acid synthase with anticancer activity
Clinical Cancer Research, Vol. 15, Núm. 24, pp. 7608-7615